Tag: securities laws

Carlsbad, CA, July 23, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced an agreement between the Company and several accredited investors to exercise certain existing warrants (the “Existing Warrants”) to purchase up to an aggregate of 4,318,905 shares of common stock. The Existing Warrants had adjusted exercise prices of $1.40 and were issued by the Company on May 10, 2022; February 1, 2024; May 6, 2024; and December 13, 2024, with each exercise occurring at a reduced exercise price of $0.9047 per share.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Encompass (EHC), National Grid (NGG), or Quantum (QMCO) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Semler (SMLR), GoHealth (GOCO), or Cleveland-Cliffs (CLF) To Contact Him Directly To Discuss Their Options

Abivax Announces Launch of Public Offering

Winnipeg, MB, July 23, 2025 (GLOBE NEWSWIRE) -- EnerPure Inc. (“EnerPure” or the “Company”), a waste to energy company, is pleased to announce the appointment of Gary Farrar, Susan Rohac, and Mogens L. Mathiesen as Advisory Board Members. Each of these newly appointed Advisors brings significant industry experience and expertise in their respective areas and their thought leadership, strategic acumen, and experience will be invaluable to management as EnerPure moves through the commercialization and growth phase.